XML 25 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Cash flows used in operating activities:        
Net loss $ (3,432) $ (3,273) $ (6,049) $ (7,296)
Adjustments:        
Depreciation expense     3 9
Gain on sale of equipment     0 (25)
Stock-based compensation     440 358
Change in fair value of derivative warrant liabilities (362) 1,826 (1,756) 1,826
Deferred income tax benefit     (1,576) (735)
Changes in operating assets and liabilities:        
Receivables     307 (35)
Prepaid expenses     (194) (446)
Trade and other payables     990 (1,986)
Operating lease right of use asset     0 (23)
Net cash used in operating activities     (7,835) (8,353)
Cash flows from investing activities:        
Proceeds from sale of equipment     0 110
Purchase of short-term investments     (15) 0
Net cash used in investing activities     (15) 110
Cash flows from financing activities:        
Net proceeds from issuance of common shares and warrants from private Placement     0 7,338
Proceeds from issuance of common shares from exercise of stock options     0 21
Net cash provided by financing activities     0 7,359
Net decrease in cash and cash equivalents     (7,850) (884)
Cash and cash equivalents, beginning of period     23,005 27,875
Cash and cash equivalents, end of period 15,155 26,991 15,155 26,991
Cash and cash equivalents are comprised of:        
Cash 1,018 10,596 1,018 10,596
Cash equivalents $ 14,137 $ 16,395 $ 14,137 $ 16,395